Correlation Between Neovacs SA and Kalray SA

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Neovacs SA and Kalray SA at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neovacs SA and Kalray SA into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neovacs SA and Kalray SA, you can compare the effects of market volatilities on Neovacs SA and Kalray SA and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neovacs SA with a short position of Kalray SA. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neovacs SA and Kalray SA.

Diversification Opportunities for Neovacs SA and Kalray SA

0.89
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Neovacs and Kalray is 0.89. Overlapping area represents the amount of risk that can be diversified away by holding Neovacs SA and Kalray SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kalray SA and Neovacs SA is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neovacs SA are associated (or correlated) with Kalray SA. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kalray SA has no effect on the direction of Neovacs SA i.e., Neovacs SA and Kalray SA go up and down completely randomly.

Pair Corralation between Neovacs SA and Kalray SA

Assuming the 90 days trading horizon Neovacs SA is expected to under-perform the Kalray SA. In addition to that, Neovacs SA is 2.69 times more volatile than Kalray SA. It trades about -0.17 of its total potential returns per unit of risk. Kalray SA is currently generating about -0.15 per unit of volatility. If you would invest  2,190  in Kalray SA on August 24, 2024 and sell it today you would lose (2,080) from holding Kalray SA or give up 94.98% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy82.14%
ValuesDaily Returns

Neovacs SA  vs.  Kalray SA

 Performance 
       Timeline  
Neovacs SA 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Neovacs SA has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in December 2024. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.
Kalray SA 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Kalray SA has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in December 2024. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Neovacs SA and Kalray SA Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Neovacs SA and Kalray SA

The main advantage of trading using opposite Neovacs SA and Kalray SA positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neovacs SA position performs unexpectedly, Kalray SA can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kalray SA will offset losses from the drop in Kalray SA's long position.
The idea behind Neovacs SA and Kalray SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Other Complementary Tools

Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device